793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

F. Cappuzzo, S. Novello, F. De Marinis, M. Maur, G. Scagliotti, S. Salvagni, E. Crucitta, S. Bartolini, A. Maestri, L. Crino
  • European Journal of Cancer Supplements, September 2003, Elsevier
  • DOI: 10.1016/s1359-6349(03)90818-4

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Federico Cappuzzo